Respiratory Infections News

Standardized patient evaluations of tuberculosis care in India revealed a low level of compliance by health care providers with established guidelines, according to recent findings from a pilot study published in Lancet Infectious Diseases.

Radial endobronchial ultrasound-guided bronchoscopy appeared useful for the diagnosis of peripheral lung lesions in a region with high incident tuberculosis, according to results of a retrospective study.

The combination of tuberculin skin testing and peripheral blood monocyte count helped physicians identify people with Mycobacterium tuberculosis at risk for progression to tuberculosis, according to recently published data.

The National Institutes of Health has awarded researchers a 4-year, $2,075,078 grant to reduce the course of time anti-tuberculosis drugs typically take to cure the disease, according to a press release.

Local “hot spots” of increased risk appeared to play a key role in disease transmission during a multidrug-resistant tuberculosis epidemic in Lima, Peru, according to recent data.

Saint Louis University’s Center for vaccine Development has received a $2.9 million award from the Bill & Melinda Gates Foundation to study a new tuberculosis vaccine, according to a press release.

Individuals working in artisanal small-scale gold mines in Tanzania were exposed to airborne crystalline silica levels that were 337 times greater than the recommended limit set by U.S. safety standards, according to study results.

Researchers from Case Western Reserve received grants from the NIH and the Bill and Melinda Gates Foundation to assess Mycobacterium tuberculosis-resistant populations for the treatment and prevention of tuberculosis, according to a press release.

Although more sensitive tuberculosis tests are still necessary, a program that used better diagnostics and on-site provider training improved TB detection and treatment outcomes in settings without a medical officer, according to prospective, quasi-experimental study results.

Blood-based biomarkers located on Mycobacterium tuberculosis-specific CD4 T-cells discriminated between pulmonary active tuberculosis and latent infections, according to recently published data.